In 8 Bio Inc (INAB)

Jun 11, 2025

U.S. Food and Drug Administration Approves Nuvation Bio's IBTROZI™ (taletrectinib), a Next-Generation Oral Treatment for Advanced ROS1-Positive Non-Small Cell Lung Cancer - Quantisnow

Jun 11, 2025

Jun 10, 2025

Layoff Tracker: National Resilience Closes 60% of Its Manufacturing Footprint - BioSpace

Jun 10, 2025

Jun 09, 2025

IN8bio Recognizes Achievement of 4-Years in Remission for Patient Treated with INB-200 in Glioblastoma Trial - GlobeNewswire Inc.

Jun 09, 2025

Jun 03, 2025

European Launch: TELA Bio's Natural Hernia Repair Device Shows 98.8% Success Rate - Stock Titan

Jun 03, 2025

Jun 02, 2025

TELA Bio Appoints Jeffrey Blizard as President - GlobeNewswire

Jun 02, 2025

May 29, 2025

Pre-market Movers: ALZN, HCTI, REVB, NTLA... - RTTNews

May 29, 2025

May 29, 2025

KALA BIO to Present at Jefferies Global Healthcare Conference - GlobeNewswire

May 29, 2025

May 28, 2025

Analysts Set Cabaletta Bio, Inc. (NASDAQ:CABA) Price Target at $20.33 - MarketBeat

May 28, 2025

May 27, 2025

Palisade Bio Reports Positive Phase 1a Results for PALI-2108, a First-in-Class Terminal Ileum and Colon-Targeted PDE4 B/D Inhibitor for Fibrostenotic Crohn’s Disease and Ulcerative Colitis - GlobeNewswire

May 27, 2025

May 27, 2025

Global Immunoprecipitation Market Set to Grow at a CAGR of 6-8%: Key Drivers and Challenges by 2029 - PharmiWeb.com

May 27, 2025

May 26, 2025

DNA Polymerase Market to Grow at 6–8% CAGR Driven by Genomics, PCR, and CRISPR Technologies by 2029 - PharmiWeb.com

May 26, 2025

May 22, 2025

GRI Bio Presents Positive Pre-Clinical Data Demonstrating - GlobeNewswire

May 22, 2025

May 20, 2025

Caisse Française de Financement Local: EMTN 2025-8 SOCIAL - The Manila Times

May 20, 2025

May 19, 2025

Protagenic Therapeutics Completes Acquisition of Phytanix Bio - TipRanks

May 19, 2025

May 18, 2025

Dimensional Fund Advisors LP Sells 592,968 Shares of bluebird bio, Inc. (NASDAQ:BLUE) - Defense World

May 18, 2025

May 14, 2025

KALA BIO: Q1 Earnings Snapshot - The Washington Post

May 14, 2025

May 14, 2025

KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 14, 2025

May 14, 2025

Raymond James Financial Inc. Takes Position in 8×8, Inc. (NASDAQ:EGHT) - Defense World

May 14, 2025

May 13, 2025

Why INmune Bio Inc (INMB) Is Skyrocketing So Far In 2025 - MSN

May 13, 2025

May 13, 2025

INmune Bio, Inc. (NASDAQ:INMB) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025

May 12, 2025

Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation - GlobeNewswire

May 12, 2025

May 11, 2025

TELA Bio, Inc. (NASDAQ:TELA) Q1 2025 Earnings Call Transcript - Insider Monkey

May 11, 2025

May 09, 2025

8 Best Medical Simulators On Steam, Ranked - Game Rant

May 09, 2025

May 09, 2025

Nuvation Bio Inc. (NUVB): Among Billionaire David Abrams’ Stock Picks with Huge Upside Potential - Yahoo Finance

May 09, 2025

May 08, 2025

bluebird bio, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 28, 2024 to Discuss Your RightsBLUE - ACCESS Newswire

May 08, 2025

May 08, 2025

Shareholders that lost money on bluebird bio, Inc. (BLUE) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

May 08, 2025

May 08, 2025

INmune Bio Inc. Announces First Quarter 2025 Results and Provides Business Update - Yahoo Finance

May 08, 2025

May 08, 2025

TELA Bio Reports First Quarter 2025 Financial Results - Yahoo Finance

May 08, 2025

May 08, 2025

GRI Bio’s Interim Biomarker Data Demonstrate Positive Trend Towards Anti-Fibrotic Effect of GRI-0621 in First Twelve Patients of Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”) - Yahoo Finance

May 08, 2025

May 07, 2025

TELA Bio Inc (TELA) Q1 2025 Earnings Report Preview: What to Expect - Yahoo Finance

May 07, 2025

May 07, 2025

GRI Bio Continues to Drive Enrollment in Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”) - Yahoo Finance

May 07, 2025

May 07, 2025

INmune Bio Inc (INMB) Q1 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

May 07, 2025

May 06, 2025

TELA Bio Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView

May 06, 2025

May 06, 2025

Instil Bio Inc expected to post a loss of $2.59 a shareEarnings Preview - TradingView

May 06, 2025

May 06, 2025

Palisade Bio Presents Positive Preclinical Data Highlighting Potential of PALI-2108 as a Promising Colon-Specific PDE4 Inhibitor for the Treatment of Ulcerative Colitis and Other Inflammatory Bowel Diseases - GlobeNewswire

May 06, 2025

May 05, 2025

INmune Bio Inc. to Report First Quarter 2025 Financial Results and Provide Corporate Update on Thursday, May 8th - The Manila Times

May 05, 2025

May 02, 2025

Gritstone bio, Inc. (GRTS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire

May 02, 2025

May 01, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 01, 2025

May 01, 2025

Nuvation Bio CFO to Share Latest Oncology Strategy at Exclusive Citizens Conference Next Week - Stock Titan

May 01, 2025

May 01, 2025

Palisade Bio’s AI-Driven Approach to IBD Heterogeneity and - GlobeNewswire

May 01, 2025

Apr 30, 2025

Phase 1a trial for THN391 yields positive results - Ophthalmology Times

Apr 30, 2025

Apr 29, 2025

Annovis Bio Appoints Hui Liu as Director of Biostatistics - GlobeNewswire

Apr 29, 2025

Apr 29, 2025

Belite Bio Announces Poster Presentations at the Association for Research in Vision and Ophthalmology 2025 Annual Meeting - Yahoo Finance

Apr 29, 2025

Apr 27, 2025

Cerity Partners LLC Makes New Investment in Nuvation Bio Inc. (NYSE:NUVB) - Defense World

Apr 27, 2025

Apr 25, 2025

Tevogen Bio Announces 2025 Annual Meeting - GlobeNewswire

Apr 25, 2025

Apr 20, 2025

TELA Bio to Announce Q1 2025 Earnings on May 8 - MSN

Apr 20, 2025